**PTALT0AE0002 - Common Stock **

We assign a fundamental rating of **6** out of 10 to **ALTR**. **ALTR** was compared to 5 industry peers in the **Paper & Forest Products** industry. **ALTR** has a great profitability rating, but there are some minor concerns on its financial health. **ALTR** has a valuation in line with the averages, but on the other hand it scores bad on growth

ROA (28.55%) VS Industry: 100% outperformed.

6.19

28.55

ROE (75.55%) VS Industry: 100% outperformed.

21.57

75.55

Profit Margin (44.39%) VS Industry: 100% outperformed.

10.15

44.39

The **Price/Earnings Ratio** is **6.24**, which indicates a rather cheap valuation of **ALTR**.

With a **Forward Price/Earnings Ratio** of **9.90**, the valuation of **ALTR** can be described as very reasonable.

When comparing the current price to the book value of **ALTR**, we can conclude it is valued correctly. It is trading at **1.72** times its book value.

Compared to an average industry price book ratio of 1.27, **ALTR** is valued more expensive than its industry peers.

Price/Earnings (6.24) VS Industry: 33% outperformed.

7.17

4.10

Price/Book (1.72) VS Industry: 25% outperformed.

1.87

0.90

The **Revenue** has grown by **39.56%** in the past year. This is a very strong growth!

Measured over the past 5 years, **ALTR** shows a small growth in **Earnings Per Share**. The EPS has been growing by **9.96%** on average per year.

Based on estimates for the next 5 years, **ALTR** will show a decrease in **Revenue**. The Revenue will decrease by **-1.95%** on average per year.

The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 9.96% | -13.99% | 54.08% | 33.55% | -11.42% | -12.35% | -7.97% |

Revenue | 5.33% | 0.36% | 39.56% | 15.93% | 0.95% | -2.37% | -1.95% |

The Altman-Z score of **ALTR** is much better than the industry average of **1.88**.

A Current Ratio of **1.40** indicates that **ALTR** should not have too much problems paying its short term obligations.

The Quick Ratio is in line with the industry averages, which is at **1.11**.

The Piotroski-F score of **ALTR** is **6.00**. This is a neutral score and indicates average health and profitability for **ALTR**.

Debt/Equity (0.94) VS Industry: 0% outperformed.

0.94

0.45

Quick Ratio (1.11) VS Industry: 50% outperformed.

0.59

1.58

Current Ratio (1.4) VS Industry: 50% outperformed.

1.03

2.01

Altman-Z (2.29) VS Industry: 75% outperformed.

0.76

2.78

With a **Yearly Dividend Yield** of **5.25%**, **ALTR** is a good candidate for dividend investing.

With a **Dividend Yield** of **5.25**, **ALTR** pays less dividend than the industry average, which is at **9.00**. 100% of the companies listed in the same industry pay a better dividend than **ALTR**!

The dividend of **ALTR** decreases each year by **-48.21%**.

Dividend Yield (5.25%) VS Industry: 0% outperformed.

5.25

10.26

ELI:ALTR (3/31/2023, 7:00:00 PM)**-0.07 (-1.37%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryPaper & Forest Products

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap973.56M

Analysts76.67

Price Target6.68 (40.75%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.25% |

Dividend Growth(5Y)-48.21%

DP18.49%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)7.72%

Min EPS beat(2)-25.49%

Max EPS beat(2)40.93%

EPS beat(4)1

Avg EPS beat(4)-3.21%

Min EPS beat(4)-26.92%

Max EPS beat(4)40.93%

Revenue beat(2)2

Avg Revenue beat(2)3.08%

Min Revenue beat(2)2.47%

Max Revenue beat(2)3.69%

Revenue beat(4)2

Avg Revenue beat(4)-8.15%

Min Revenue beat(4)-35.06%

Max Revenue beat(4)3.69%

PT rev (1m)0%

PT rev (3m)-5.76%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-7.83%

EPS NY rev (3m)-7.83%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-8.33%

Revenue NY rev (1m)1.13%

Revenue NY rev (3m)1.13%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 6.24 | ||

Fwd PE | 9.9 | ||

P/S | 1.01 | ||

P/FCF | 8.48 | ||

P/OCF | 5.76 | ||

P/B | 1.72 | ||

P/tB | 3.24 | ||

EV/EBITDA | N/A |

EPS(TTM)0.76

EY16.01%

EPS(NY)0.48

Fwd EY10.1%

FCF(TTM)0.56

FCFY11.79%

OCF(TTM)0.82

OCFY17.36%

SpS4.7

BVpS2.76

TBVpS1.47

PEG (NY)0.19

PEG (5Y)0.63

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 28.55% | ||

ROE | 75.55% | ||

ROIC | 13.63% | ||

ROICexc | 16.34% | ||

ROICexgc | 22.6% | ||

OM | 19.76% | ||

PM | 44.39% | ||

GM | 31.13% |

ROICexgc(3y)10.87%

ROICexcg growth 3Y-35.1%

ROICexcg growth 5Y-13.4%

ROICexc(3y)7.91%

ROICexc growth 3Y-29.01%

ROICexc growth 5Y-8.88%

OM growth 3Y-12.54%

OM growth 5Y1.42%

PM growth 3Y-13.37%

PM growth 5Y5.07%

GM growth 3Y-7.87%

GM growth 5Y0.26%

F-Score6

Asset Turnover0.64

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.94 | ||

Debt/FCF | 5.51 | ||

Debt/EBITDA | N/A | ||

Cap/Depr | N/A | ||

Profit Quality | 26.84% | ||

Current Ratio | 1.4 | ||

Quick Ratio | 1.11 | ||

Altman-Z | 2.29 |

F-Score6

WACC7.88%

ROIC/WACC2.87

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Profit Quality(3y)207.53%

Profit Quality(5y)167.52%

Growth

EPS 1Y54.08%

EPS 3Y-13.99%

EPS 5Y9.96%

EPS growth Q2Q0%

EPS Next Y33.55%

EPS Next 2Y-11.42%

EPS Next 3Y-12.35%

EPS Next 5Y-7.97%

Revenue growth 1Y39.56%

Revenue growth 3Y0.36%

Revenue growth 5Y5.33%

Revenue growth Q2Q30.63%

Revenue Next Year15.93%

Revenue Next 2Y0.95%

Revenue Next 3Y-2.37%

Revenue Next 5Y-1.95%

EBIT growth 1Y50.77%

EBIT growth 3Y-12.23%

EBIT growth 5Y6.82%

EBIT Next Year53.21%

EBIT Next 3Y-2.5%

EBIT Next 5Y-0.08%

FCF growth 1Y-8.01%

FCF growth 3Y5.01%

FCF growth 5Y23.43%

OCF growth 1Y1.81%

OCF growth 3Y3.7%

OCF growth 5Y20.89%

*Find stocks with similar Fundamental rating on the EuroNext*

*Find the competitors with the best fundamentals on the EuroNext*

*Find the competitors with the best valuation on the EuroNext*

*Find the competitors with the best dividend on the EuroNext*